Valo Announces Technology & Product Management Expert Nish Lathia as Chief Product Officer

Leading expert in product, engineering, program management, and user experience will be a crucial member of the Valo leadership team

BOSTON, March 1, 2021 /​PRNewswire/​— Valo Health LLC (Valo), the tech­nol­o­gy com­pa­ny work­ing to trans­form the drug dis­cov­ery and devel­op­ment process and accel­er­ate the cre­ation of life-chang­ing drugs, today announced the appoint­ment of Nish Lath­ia as Chief Prod­uct Offi­cer (CPO), a new­ly estab­lished exec­u­tive lead­er­ship posi­tion at the company.

As a lead­ing expert in prod­uct, engi­neer­ing, pro­gram man­age­ment, and user expe­ri­ence, Nish will be a cru­cial mem­ber of the Valo lead­er­ship team, report­ing to David Berry, Ph.D., Valo founder, and CEO. As CPO, Nish will help dri­ve Val­o’s busi­ness mod­el and fur­ther devel­op, scale and sup­port the Opal Com­pu­ta­tion­al Plat­form™, the first closed-loop, human-cen­tric, active-learn­ing, end-to-end inte­grat­ed, drug dis­cov­ery and devel­op­ment platform.

I am thrilled that Nish has joined the exec­u­tive team at Valo,” said David Berry. He brings a tremen­dous skill set and back­ground in plat­form devel­op­ment, soft­ware prod­uct man­age­ment, and strat­e­gy. As Val­o’s Opal plat­form evolves and con­tin­ues to demon­strate its abil­i­ty to accel­er­ate the drug devel­op­ment process, we see the need to fur­ther scale Opal. Nish’s exper­tise will be invalu­able to help dri­ve this growth.”

I look for­ward to work­ing with the team to help expand the depth of the plat­form and help dri­ve Val­o’s busi­ness mod­el,” Lath­ia added. Our work will build a pow­er­ful engi­neer­ing and prod­uct team on the foun­da­tion that Valo has devel­oped over the last two years,” Lath­ia said.

Lath­ia has close to 23 years of indus­try expe­ri­ence includ­ing the last 18 years at Ama­zon where he envi­sioned, launched, and scaled var­i­ous Ama­zon busi­ness­es world­wide rang­ing from parts of Ama­zon’s Retail busi­ness to a num­ber of AWS ser­vices. These busi­ness­es have grown to be large and loved by mil­lions of cus­tomers, part­ners, and devel­op­ers. Lath­i­a’s obses­sive cus­tomer focus, deep curios­i­ty, and wealth of prod­uct, tech­nol­o­gy, and oper­a­tions knowl­edge will be an extra­or­di­nary addi­tion to Valo. In addi­tion, his expe­ri­ence of build­ing plat­forms and nur­tur­ing part­ner ecosys­tems will be invalu­able to enable Valo to accel­er­ate its vision of trans­form­ing the drug R&D process from tar­get dis­cov­ery through drug development.

About Valo
Valo Health, LLC (Valo) is a tech­nol­o­gy com­pa­ny that is using human-cen­tric data and machine learn­ing com­pu­ta­tion to trans­form the drug dis­cov­ery and devel­op­ment process. As a dig­i­tal­ly native com­pa­ny, Valo is the first to ful­ly inte­grate human-cen­tric data across the entire drug devel­op­ment life­cy­cle into a sin­gle uni­fied archi­tec­ture, there­by accel­er­at­ing the dis­cov­ery and devel­op­ment of life-chang­ing drugs while simul­ta­ne­ous­ly reduc­ing the cost, time, and fail­ure rate. The com­pa­ny’s Opal Com­pu­ta­tion­al Plat­form™, a ful­ly inte­grat­ed, com­pu­ta­tion­al, end-to-end drug devel­op­ment plat­form, offers a unique approach to ther­a­peu­tic devel­op­ment that enables Valo to advance a robust pipeline of can­di­dates across car­dio­vas­cu­lar dis­ease, oncol­o­gy, and neu­rode­gen­er­a­tion. Found­ed by Flag­ship Pio­neer­ing and head­quar­tered in Boston, MA, Valo has offices in Lex­ing­ton, MA, San Fran­cis­co, CA, Prince­ton, NJ, and in Bran­ford, CT. To learn more, vis­it www​.val​o​health​.com.